All Stories

  1. Metacognitive therapy and work-focus for patients with depression, anxiety or comorbid depression and anxiety on sick leave: a single-centre, open-label randomised controlled trial
  2. Do Parental Psychopathology and Higher‐Order Beliefs Predict Symptom Changes in Young People Following Metacognitive Therapy?
  3. Relationships between anxiety, depression and wound healing outcomes in adults: A systematic review and meta-analysis
  4. Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial
  5. Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: The PATHWAY Research Programme Including 4 RCTs
  6. Relationships between metacognitive beliefs and anxiety and depression in children and adolescents: A meta-analysis
  7. Cardiac rehabilitation for children and young people (CardioActive): protocol for a single-blind randomised feasibility and acceptability study of a centre-based cardiac rehabilitation programme versus usual care in 11–16 years with heart conditions
  8. Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial
  9. A framework for implementing Patient and Public Involvement in mental health research: The PATHWAY research programme benchmarked against NIHR standards
  10. The Effectiveness of Metacognitive Therapy Compared to Behavioral Activation for Severely Depressed Outpatients: A Single-Center Randomized Trial
  11. Discrete choice experiment to investigate preferences for psychological intervention in cardiac rehabilitation
  12. Youth Metacognitive Therapy (YoMeta): protocol for a single-blind randomised feasibility trial of a transdiagnostic intervention versus treatment as usual in 11–16-year-olds with common mental health problems
  13. Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
  14. Self-help metacognitive therapy for anxiety and depression in heart patients
  15. Metacognitive therapy and work-focused interventions for patients on sick leave due to anxiety and depression: study protocol for a randomised controlled wait-list trial
  16. Metacognitive Beliefs and Suicidal Ideation: An Experience Sampling Study
  17. Metacognition, rumination and suicidal ideation: An experience sampling test of the self-regulatory executive function model
  18. Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY—A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy
  19. Cardiac rehabilitation patients experiences and understanding of group metacognitive therapy: a qualitative study
  20. Covid-19, Lockdown and Self-Isolation: Evaluation of Deliberate Self-Harm Admissions
  21. Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: A systematic review
  22. Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression
  23. Utilising Patient and Public Involvement in Stated Preference Research in Health: Learning from the Existing Literature and a Case Study
  24. Author Correction: Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial
  25. Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study
  26. Metacognition in Cardiac Patients With Anxiety and Depression: Psychometric Performance of the Metacognitions Questionnaire 30 (MCQ-30)
  27. Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial
  28. Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life
  29. Breaking the Cybernetic Code: Understanding and Treating the Human Metacognitive Control System to Enhance Mental Health
  30. What Comes First Metacognition or Negative Emotion? A Test of Temporal Precedence
  31. Measuring the Cognitive Attentional Syndrome in Cardiac Patients With Anxiety and Depression Symptoms: Psychometric Properties of the CAS-1R
  32. Testing relationships between metacognitive beliefs, anxiety and depression in cardiac and cancer patients: Are they transdiagnostic?
  33. A Comparison of Metacognitive Therapy in Current Versus Persistent Depressive Disorder – A Pilot Outpatient Study
  34. Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial
  35. A Preliminary Evaluation of Transdiagnostic Group Metacognitive Therapy in a Mixed Psychological Disorder Sample
  36. Modeling the Relationships Between Metacognitive Beliefs, Attention Control and Symptoms in Children With and Without Anxiety Disorders: A Test of the S-REF Model
  37. Cardiac Rehabilitation Patients’ Accounts of Their Emotional Distress and Psychological Needs: A Qualitative Study
  38. Metacognition, Hardiness, and Grit as Resilience Factors in Unmanned Aerial Systems (UAS) Operations: A Simulation Study
  39. In or out of work: A preliminary investigation of mental health, trait anxiety and metacognitive beliefs as predictors of work status
  40. What Lies Beneath Trait-Anxiety? Testing the Self-Regulatory Executive Function Model of Vulnerability
  41. Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective?
  42. Metacognitive Therapy for Alcohol Use Disorder: A Systematic Case Series
  43. Group Cognitive-Behavior Therapy or Group Metacognitive Therapy for Obsessive-Compulsive Disorder? Benchmarking and Comparative Effectiveness in a Routine Clinical Service
  44. Single Dose of the Attention Training Technique Increases Resting Alpha and Beta-Oscillations in Frontoparietal Brain Networks: A Randomized Controlled Comparison
  45. Metacognitive therapy (MCT) vs. Cognitive behavioural therapy (CBT) in generalised anxiety disorder
  46. Brief Cognitive Therapy Plus Treatment as Usual for Social Anxiety Disorder: a Randomized Trial of Adults in India
  47. Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT)
  48. Effects of the Attention Training Technique on Auditory Hallucinations in Schizo-Affective Disorder: A Single Case Study
  49. Assessment of metacognitive beliefs in an at risk mental state for psychosis: A validation study of the Metacognitions Questionnaire-30
  50. Letter to the editor: Metacognitive therapy or metacognitive training: What's in a name?
  51. The Attention Training Technique improves Children's ability to delay gratification: A controlled comparison with progressive relaxation
  52. Cost-effectiveness of cardiac rehabilitation: a systematic review
  53. Metacognitive Therapy for Social Anxiety Disorder: An A–B Replication Series Across Social Anxiety Subtypes
  54. Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial
  55. Metacognitive beliefs as psychological predictors of social functioning: An investigation with young people at risk of psychosis
  56. Explaining depression symptoms in patients with social anxiety disorder: Do maladaptive metacognitive beliefs play a role?
  57. Worry and rumination: do they prolong physiological and affective recovery from stress?
  58. Metacognitive therapy vs. eye movement desensitization and reprocessing for posttraumatic stress disorder: study protocol for a randomized superiority trial
  59. Neurophysiological correlates of the attention training technique: A component study
  60. Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample
  61. Group Metacognitive Therapy vs. Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Randomised Feasibility Trial
  62. The effect of thought importance on stress responses: a test of the metacognitive model
  63. Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study
  64. The role of cognitive and metacognitive factors in non-clinical paranoia and negative affect
  65. Individual differences in metacognitive knowledge contribute to psychological vulnerability more than the presence of a mental disorder does
  66. Social cognition and metacognition in social anxiety: A systematic review
  67. Are experiences of psychosis associated with unhelpful metacognitive coping strategies? A systematic review of the evidence
  68. Metacognitive Therapy in Major Depression: An Open Trial of Comorbid Cases
  69. Predictors of Biased Self-perception in Individuals with High Social Anxiety: The Effect of Self-consciousness in the Private and Public Self Domains
  70. Social anxiety and work status: the role of negative metacognitive beliefs, symptom severity and cognitive-behavioural factors
  71. An exploration of the relationship between use of safety-seeking behaviours and psychosis: A systematic review and meta-analysis
  72. Testing the metacognitive model against the benchmark CBT model of social anxiety disorder: Is it time to move beyond cognition?
  73. ‘You've got your own demons that you've got to fight every day’: A qualitative exploration of how people respond to the experience of psychosis
  74. Cognitive and metacognitive predictors of symptom improvement following treatment for social anxiety disorder: A secondary analysis from a randomized controlled trial
  75. Measuring common responses to psychosis: Assessing the psychometric properties of a new measure
  76. Metacognitive beliefs and rumination as predictors of anger: A prospective study
  77. Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up
  78. Rumination
  79. A meta-analysis of metacognitive beliefs as implicated in the self-regulatory executive function model in clinical psychosis
  80. The role of unhelpful metacognitive beliefs in psychosis: Relationships with positive symptoms and negative affect
  81. Experimental modification of perspective on thoughts and metacognitive beliefs in alcohol use disorder
  82. Is metacognition a causal moderator of the relationship between catastrophic misinterpretation and health anxiety? A prospective study
  83. Can the attention training technique turn one marshmallow into two? Improving children's ability to delay gratification
  84. SSRI vs Cognitive therapy in patients with social phobia
  85. Metacognitive beliefs moderate the relationship between catastrophic misinterpretation and health anxiety
  86. Metacognition in addictive behaviors
  87. The Metacognitions about Smoking Questionnaire: Development and psychometric properties
  88. Early trauma, negative affect, and anxious attachment: the role of metacognition
  89. Emotion regulation as a mediator in the relationship between attachment and depressive symptomatology: A systematic review
  90. Unique Contributions of Metacognition and Cognition to Depressive Symptoms
  91. Refraining from Intrusive Thoughts is Strategy Dependent: A Comment on Sugiura, et al. and a Preliminary Informal Test of Detached Mindfulness, Acceptance, and other Strategies
  92. An open trial of group metacognitive therapy for depression in Norway
  93. How to Deal with Negative Thoughts? A Preliminary Comparison of Detached Mindfulness and Thought Evaluation in Socially Anxious Individuals
  94. Metacognitive Therapy Versus Prolonged Exposure in Adults with Chronic Post-traumatic Stress Disorder: A Parallel Randomized Controlled Trial
  95. Schizophrenia and Metacognition: An Investigation of Course of Illness and Metacognitive Beliefs Within a First Episode Psychosis
  96. A Randomised Controlled Study of the Effects of the Attention Training Technique on Traumatic Stress Symptoms, Emotional Attention Set Shifting and Flexibility
  97. Group Metacognitive Therapy for Severe Antidepressant and CBT Resistant Depression: A Baseline-Controlled Trial
  98. Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: A feasibility study
  99. Metacognitive therapy in recurrent depression: A case replication series in Denmark
  100. Attention Training Reduces Intrusive Thoughts Cued by a Narrative of Stressful Life Events: A Controlled Study
  101. Metacognitive Therapy for Generalized Anxiety Disorder: Nature, Evidence and an Individual Case Illustration
  102. Advances in Metacognitive Therapy
  103. Metacognitive beliefs in adolescents with an at-risk mental state for psychosis
  104. An experimental manipulation of metacognition: A test of the metacognitive model of obsessive-compulsive symptoms
  105. Metacognitive Therapy in Treatment-Resistant Psychosis: A Multiple-Baseline Study
  106. Does Metacognition Make a Unique Contribution to Health Anxiety When Controlling for Neuroticism, Illness Cognition, and Somatosensory Amplification?
  107. A Multiple‐Baseline Study of the Effects Associated With Metacognitive Therapy in Postpartum Depression
  108. Automatic thoughts and meta-cognition as predictors of depressive or anxious symptoms: A prospective study of two trajectories
  109. On the relationship between temperament, metacognition, and anxiety: independent and mediated effects
  110. Metacognition and Obsessive-Compulsive Symptoms: The Contribution of Thought-Fusion Beliefs and Beliefs about Rituals
  111. Development and Preliminary Validation of the Thought Control Questionnaire for Adolescents (TCQ-A)
  112. Metacognitive therapy in treatment-resistant depression: A platform trial
  113. A Triphasic Metacognitive Formulation of Problem Drinking
  114. Treating Posttraumatic Stress Disorder With Metacognitive Therapy: A Preliminary Controlled Trial
  115. Metacognitive Therapy
  116. Social Metacognition
  117. Metacognitions and negative emotions as predictors of symptom severity in chronic fatigue syndrome
  118. The temporal precedence of metacognition in the development of anxiety and depression symptoms in the context of life-stress: A prospective study
  119. Meta-Cognitive Therapy Without Metacognition: A Case of ADHD
  120. Metacognition and persecutory delusions: Tests of a metacognitive model in a clinical population and comparisons with non-patients
  121. Conceptual Models of Generalized Anxiety Disorder
  122. Generalized anxiety disorder
  123. Metacognitions across the continuum of drinking behaviour
  124. Association Between Abnormal Psychosocial Situations in Childhood, Generalized Anxiety Disorder and Oppositional Defiant Disorder
  125. A pilot randomized trial of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder
  126. Metacognition, memory disorganization and rumination in posttraumatic stress symptoms
  127. An empirical test of the metacognitive model of obsessive-compulsive symptoms: Replication and extension
  128. Metacognitive Theory and Therapy for Worry and Generalized Anxiety Disorder: Review and Status
  129. Metacognitions as a predictor of drinking status and level of alcohol use following CBT in problem drinkers: A prospective study
  130. Treatment Resistant Anxiety Disorders
  131. The Relationship among Metacognitions, Attentional Control, and State Anxiety
  132. A metacognitive model of problem drinking
  133. Imagery rescripting as a brief stand-alone treatment for depressed patients with intrusive memories
  134. A Prospective Test of the Clinical Metacognitive Model of Rumination and Depression
  135. Metacognition and Cognition as Predictors of Obsessive-Compulsive Symptoms: A Prospective Study
  136. An empirical test of the metacognitive model of obsessive-compulsive symptoms: Fusion beliefs, beliefs about rituals, and stop signals
  137. Change in metacognitions predicts outcome in obsessive–compulsive disorder patients undergoing treatment with exposure and response prevention
  138. Metacognitive Therapy: Cognition Applied To Regulating Cognition
  139. Psychometric characteristics of the Penn State Worry Questionnaire and Metacognitions Questionnaire-30 and metacognitive predictors of worry and obsessive-compulsive symptoms in a Turkish sample
  140. Psychological Models of Worry and Generalized Anxiety Disorder
  141. Treating Bulimia Nervosa and Binge Eating
  142. Measuring metacognitions associated with emotional distress: Factor structure and predictive validity of the metacognitions questionnaire 30
  143. Psychological factors predicting stress symptoms: Metacognition, thought control, and varieties of worry
  144. Metacognitive therapy for obsessive–compulsive disorder: A case series
  145. Cognitive Therapy for Generalised Anxiety Disorder
  146. Cognitive Therapy for Social Phobia
  147. Identifying Specific Interpretations and Exploring the Nature of Safety Behaviours for People Who Hear Voices: An Exploratory Study
  148. Belief domains of the Obsessive Beliefs Questionnaire-44 (OBQ-44) and their specific relationship with obsessive–compulsive symptoms
  149. Metacognition, perceived stress, and negative emotion
  150. Metacognitive beliefs about alcohol use: Development and validation of two self-report scales
  151. Chronic PTSD Treated With Metacognitive Therapy: An Open Trial
  152. Metacognitive Therapy in Recurrent and Persistent Depression: A Multiple-Baseline Study of a New Treatment
  153. “I’ll believe it when I can see it”: Imagery rescripting of intrusive sensory memories in depression
  154. Intrusive images and memories in major depression
  155. Metacognition as a mediator of the relationship between emotion and smoking dependence
  156. Metacognitive beliefs across the continuum of psychosis: Comparisons between patients with psychotic disorders, patients at ultra-high risk and non-patients
  157. The relative contribution of metacognitive beliefs and expectancies to drinking behaviour
  158. Relationships between worry, psychotic experiences and emotional distress in patients with schizophrenia spectrum diagnoses and comparisons with anxious and non-patient groups
  159. Belief disconfirmation versus habituation approaches to situational exposure in panic disorder with agoraphobia: A pilot study
  160. The Attention Training Technique: Theory, Effects, and a Metacognitive Hypothesis on Auditory Hallucinations
  161. Cognition About Cognition: Metacognitive Therapy and Change in Generalized Anxiety Disorder and Social Phobia
  162. Cognitive therapy for bulimia nervosa: an A-B replication series
  163. Assessing Eating Disorder Thoughts and Behaviors: The Development and Preliminary Evaluation of Two Questionnaires
  164. Metacognitions in Problem Drinkers
  165. Case Formulation in Cognitive Behaviour Therapy
  166. Does maternal psychopathology discriminate between children with DSM-IV generalised anxiety disorder or oppositional defiant disorder? The predictive validity of maternal axis I and axis II psychopathology
  167. Metacognitive therapy for generalized anxiety disorder: An open trial
  168. Cognitive Vulnerability to Emotional Disorders
  169. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics
  170. Cognitive Processes, Reasoning Biases and Persecutory Delusions: A Comparative Study
  171. Worry and its Psychological Disorders
  172. Metacognitions about alcohol use in problem drinkers
  173. Post-traumatic stress symptoms: Tests of relationships with thought control strategies and beliefs as predicted by the metacognitive model
  174. Detached Mindfulness In Cognitive Therapy: A Metacognitive Analysis And Ten Techniques
  175. How effective are cognitive and behavioral treatments for obsessive–compulsive disorder? A clinical significance analysis
  176. Distress in Parkinson's disease: Contributions of disease factors and metacognitive style
  177. Experimental modification of beliefs in obsessive–compulsive disorder: a test of the metacognitive model
  178. The Metacognitive Model of GAD: Assessment of Meta-Worry and Relationship With DSM-IV Generalized Anxiety Disorder
  179. Metacognitions, emotion and alcohol use
  180. Obsessive-compulsive symptoms: the contribution of metacognitions and responsibility
  181. Metacognitive therapy for PTSD: a preliminary investigation of a new brief treatment
  182. Interpretations of voices in patients with hallucinations and non-patient controls: a comparison and predictors of distress in patients
  183. Childhood adversity and frequent medical consultations
  184. Metacognitive therapy for PTSD: A core treatment manual
  185. Psychological treatment of social phobia
  186. Analysis of thin AlN carrier exclusion layers in AlGaN/GaN microwave heterojunction field-effect transistors
  187. A short form of the metacognitions questionnaire: properties of the MCQ-30
  188. A cognitive model of bulimia nervosa
  189. Dose meta-cognition or responsibility predict obsessive–compulsive symptoms: a test of the metacognitive model
  190. Development and preliminary validation of the Meta-cognitions Questionnaire—Adolescent Version
  191. Religion and mental health: Towards a cognitive-behavioural framework
  192. A comparison of metacognitions in patients with hallucinations, delusions, panic disorder, and non-patient controls
  193. Depressive Rumination
  194. Cognitive and emotional predictors of predisposition to hallucinations in non-patients
  195. Worry, Metacognition, and GAD: Nature, Consequences, and Treatment
  196. The role of metacognitive beliefs in auditory hallucinations
  197. Death beliefs, superstitious beliefs and health anxiety
  198. GAD, Metacognition, and Mindfulness: An Information Processing Analysis
  199. Emotional Disorders and Metacognition
  200. Effects of heart rate information on anxiety, perspective taking, and performance in high and low social-evaluative anxiety
  201. GAD, metacognition, and mindfulness: An information processing analysis.
  202. Brief cognitive therapy for social phobia: a case series
  203. An experimental investigation of thought suppression and anxiety in children
  204. Metacognitive beliefs about rumination in recurrent major depression
  205. Emotional, Cognitive, and Behavioral Characteristics of Medical Outpatients
  206. Exercising for the wrong reasons: relationships among eating disorder beliefs, dysfunctional exercise beliefs and coping
  207. Further tests of a cognitive model of generalized anxiety disorder: Metacognitions and worry in GAD, panic disorder, social phobia, depression, and nonpatients
  208. Positive beliefs about depressive rumination: Development and preliminary validation of a self-report scale
  209. Prevalence and predictors of acute stress disorder and PTSD following road traffic accidents: Thought control strategies and social support
  210. Social phobic interoception: effects of bodily information on anxiety, beliefs and self-processing
  211. Thought control strategies in schizophrenia: a comparison with non-patients
  212. ERRATUM
  213. The prediction of parasuicide repetition in a high-risk group
  214. A Cognitive Model of Generalized Anxiety Disorder
  215. The Thought Control Questionnaire – psychometric properties in a clinical sample, and relationships with PTSD and depression
  216. The observer perspective: biased imagery in social phobia, agoraphobia, and blood/injury phobia
  217. An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia
  218. Preliminary tests of a cognitive model of generalized anxiety disorder
  219. Brief cognitive therapy for panic disorder: A randomized controlled trial.
  220. The Manchester bombing: Providing a rational response
  221. Relationships between worry, obsessive–compulsive symptoms and meta-cognitive beliefs
  222. Assessment of beliefs in exercise dependence: The development and preliminary validation of the exercise beliefs questionnaire
  223. How do I look with my minds eye: perspective taking in social phobic imagery
  224. Effects of attention training on hypochondriasis: a brief case series
  225. Social phobia: Effects of external attention on anxiety, negative beliefs, and perspective taking
  226. Beliefs about Worry and Intrusions: The Meta-Cognitions Questionnaire and its Correlates
  227. The Eating Disorder Belief Questionnaire: Preliminary development
  228. Anxiety and cognition
  229. Modelling cognition in emotional disorder: The S-REF model
  230. Worry and the incubation of intrusive images following stress
  231. Social phobia: The role of in-situation safety behaviors in maintaining anxiety and negative beliefs
  232. Qualitative dimensions of normal worry and normal obsessions: A comparative study
  233. The thought control questionnaire: A measure of individual differences in the control of unwanted thoughts
  234. Panic disorder in association with relaxation induced anxiety: An attentional training approach to treatment
  235. Metacognitive Therapy for Worry and Generalised Anxiety Disorder
  236. Metacognitive Therapy for Depressive Rumination
  237. Nature, Functions, and Beliefs about Depressive Rumination
  238. Rumination, Depression, and Metacognition: the S-REF Model
  239. The Anxious Thoughts Inventory and Related Measures of Metacognition and Worry
  240. The Metacognitive Model of Worry and Generalised Anxiety Disorder